Clinical Trial

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the clinical efficacy, safety and tolerability of a photodynamic therapy(PDT) based on a new photosensitizer, Chlorin-e6, in the treatment of moderate to severe acne. The hypothesis is that the therapy has good efficacy, safety and tolerability.
Trial Details
NCT Number NCT06311890
Lead Sponsor Xiyuan Hospital of China Academy of Chinese Medical Sciences
Conditions Acne, Photodynamic Therapy
Enrollment 46 participants
Start Date 2024-02-01
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-15